fda - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Live Science · 30m

FDA approves 1st new class of opioid-free painkillers in over 20 years

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

U.S. News & World Report · 4h

FDA Approves First New Non-Opioid Pain Pill in Decades

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

FDA upgrades recall of Lay's potato chips

Newsweek on MSN · 2d

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

USA TODAY on MSN · 1d

FDA upgrades Frito-Lay potato chips recall to highest risk level due to undeclared milk

Federal regulators have upgraded a product recall of Lay's Classic Potato Chips to the highest risk level for a batch that may contain undeclared milk ingredients. Last month, Frito-Lay issued a recall warning that more than 6,

Boise State Public Radio · 20h

FDA upgrades recall of Lay's potato chips to most serious level

The problem ingredient identified was "undeclared milk," which poses a risk to those with severe sensitivities or allergies.

2don MSN

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

21h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

clickondetroit.com4m

Child killed in hyperbaric chamber explosion at Oakland County healthcare facility

A 5-year-old boy from Royal Oak was killed in an explosion while receiving hyperbaric oxygen therapy at a healthcare facility ...

JD Supra30m

FDA Bans Red Dye No. 3 in Food and Ingested Drugs: What Manufacturers Should Know

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

aha.org1h

CISA, FDA warn of vulnerabilities in Contec patient monitors

The Cybersecurity and Infrastructure Security Agency and Food and Drug Administration Jan. 30 released notices warning of ...

The American Journal of Managed Care1h

FDA Approves Celltrion’s Tocilizumab-anoh, Biosimilar to Actemra

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

Live Science1h

FDA approves 'ketamine' nasal spray for depression — here's everything you need to know

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA upgrades recall of Lay's potato chips

Related topics